Jim Cramer says one of these red-hot stocks is a maybe, the other is a miss

Jim Cramer says one of these red-hot stocks is a maybe, the other is a miss


CNBC’s Jim Cramer on Thursday broke down why Alto Ingredients is a risky buy while Gladstone Land is a complete miss.

“You have my blessing to swing at Alto Ingredients for speculation, but Gladstone Land is coming in way too hot,” the “Mad Money” host said.

Alto Ingredients stock fell 0.15% on Thursday to $6.82, reaching a 52-week high of $7.27 earlier in the day. The company, which makes specialty alcohols and other ingredients derived from crops, has been able to rally recently by focusing on ethanol, Cramer said, adding that ethanol is more competitive nowadays due to high oil prices.

“While I’m wary of anything that’s up more than 40% for the year, Alto’s … a $500 million enterprise with light analyst coverage,” Cramer said. “This could be terrific material for speculation in the right environment,” he added.

However, he cautioned that this doesn’t mean he’s recommending that investors start purchasing the stock in earnest.

“In the end, it’s pure speculation. If you believe oil prices can stay elevated, then I think Alto Ingredients could be worth betting on, but I recommend buying it in gradual small increments and only with money you can afford to lose,” he said.

As for Gladstone, a farmland real estate company, Cramer said its stock price is currently too high to be a buy. The company’s stock dropped 2.72% on Thursday to $36.42.

“Long-term, I believe it’s an excellent business, and I’d be a buyer at the right price. But I don’t think the right price is this price,” Cramer said. 

“I can’t countenance buying Gladstone up here. Sometimes, you just have to admit that you’ve missed it,” he added.

Sign up now for the CNBC Investing Club to follow Jim Cramer’s every move in the market.

Disclaimer

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer’s world? Hit him up!
Mad Money TwitterJim Cramer Twitter – Facebook – Instagram

Questions, comments, suggestions for the “Mad Money” website? [email protected]





Source

FDA vaccine head will step down in April after string of controversial decisions
Business

FDA vaccine head will step down in April after string of controversial decisions

The logo for the Food and Drug Administration is seen ahead of a news conference at the Health and Human Services Headquarters in Washington, DC on April 22, 2025. Nathan Posner | Anadolu | Getty Images A key U.S. Food and Drug Administration official who oversees vaccines and biotech treatments will step down from the […]

Read More
FDA reversals leave investors worrying about the fates of other experimental drugs
Business

FDA reversals leave investors worrying about the fates of other experimental drugs

Investors are concerned about the fates of multiple experimental drugs for hard-to-treat diseases following a string of recent rejections from the U.S. Food and Drug Administration.  The FDA in the past year has denied or discouraged the applications of at least eight drugs, according to RTW Investments, including a gene therapy for Huntington’s disease from […]

Read More
Toyota, Hyundai and Chinese automakers expected to be most impacted by Iran war
Business

Toyota, Hyundai and Chinese automakers expected to be most impacted by Iran war

Toyota Motor Corp. vehicles bound for shipment at the Port of Nagoya in Tokai, Aichi Prefecture, Japan, on Tuesday, April 29, 2025. Toru Hanai | Bloomberg | Getty Images DETROIT — Toyota Motor, Hyundai Motor and Chinese automakers such as Chery face the most potential impact of non-domestic automakers from the U.S.-Israel war with Iran, […]

Read More